Literature DB >> 11761723

Dementia with Lewy bodies and Alzheimer's disease.

C K Rosenberg1, T J Cummings, A M Saunders, C Widico, L M McIntyre, C M Hulette.   

Abstract

To investigate similarities and differences between Alzheimer's disease (AD) and dementia with Lewy bodies (DLB), we undertook a demographic analysis of 277 patients from the Kathleen Price Bryan Brain Bank with an antemortem diagnosis of probable AD. Patients with additional, possibly confounding clinical and pathologic diagnoses such as infarcts, hematomas, neoplasms, and other neurodegenerative disorders, were excluded from the analysis. Neuropathologically, AD alone was present in 192 subjects (69%), and DLB was found in 85 subjects (31%). All of the DLB cases had neuropathologic evidence of AD sufficient to meet CERAD criteria for a diagnosis of definite AD plus nigral Lewy bodies. Gender, apolipoprotein E (APOE) genotype, brain weight, age at death, duration of disease and Braak stage were compared between the two groups. Statistical analyses were performed using Fisher's exact test for comparisons of categorical data and Student's t-test for comparison of means for continuous outcomes. The proportion of males and females was balanced in the combined AD and DLB populations. There was a highly statistically significant increased frequency of APOE 3/4 in males with DLB (P = 0.007). We found higher brain weights in males with DLB versus males with AD (P = 0.012). AD was more frequent in females and DLB was more frequent in males (P = 0.019). Our findings with respect to age at death, duration of disease and Braak stage within diagnostic groups confirm previously reported findings. These data suggest that Lewy bodies are more common in males affected with dementia, especially those with the APOE 3/4 genotype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11761723     DOI: 10.1007/s004010100415

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  7 in total

1.  Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease.

Authors:  D W Tsuang; R K Wilson; O L Lopez; E K Luedecking-Zimmer; J B Leverenz; S T DeKosky; M I Kamboh; R L Hamilton
Journal:  Neurology       Date:  2005-02-08       Impact factor: 9.910

2.  Cerebrovascular smooth muscle actin is increased in nondemented subjects with frequent senile plaques at autopsy: implications for the pathogenesis of Alzheimer disease.

Authors:  Christine M Hulette; John F Ervin; Yvette Edmonds; Samantha Antoine; Nicolas Stewart; Mari H Szymanski; Kathleen M Hayden; Carl F Pieper; James R Burke; Kathleen A Welsh-Bohmer
Journal:  J Neuropathol Exp Neurol       Date:  2009-04       Impact factor: 3.685

3.  Capgras syndrome in Dementia with Lewy Bodies.

Authors:  Papan Thaipisuttikul; Iryna Lobach; Yael Zweig; Ashita Gurnani; James E Galvin
Journal:  Int Psychogeriatr       Date:  2012-12-05       Impact factor: 3.878

4.  APOE ε4 increases risk for dementia in pure synucleinopathies.

Authors:  Debby Tsuang; James B Leverenz; Oscar L Lopez; Ronald L Hamilton; David A Bennett; Julie A Schneider; Aron S Buchman; Eric B Larson; Paul K Crane; Jeffrey A Kaye; Patricia Kramer; Randy Woltjer; John Q Trojanowski; Daniel Weintraub; Alice S Chen-Plotkin; David J Irwin; Jacqueline Rick; Gerard D Schellenberg; G Stennis Watson; Walter Kukull; Peter T Nelson; Gregory A Jicha; Janna H Neltner; Doug Galasko; Eliezer Masliah; Joseph F Quinn; Kathryn A Chung; Dora Yearout; Ignacio F Mata; Jia Y Wan; Karen L Edwards; Thomas J Montine; Cyrus P Zabetian
Journal:  JAMA Neurol       Date:  2013-02       Impact factor: 18.302

5.  Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer's disease.

Authors:  Robert E Mrak; W Sue T Griffin
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570

6.  Low Cerebrospinal Fluid Amyloid-Beta Concentration Is Associated with Poorer Delayed Memory Recall in Women.

Authors:  Fanni Haapalinna; Teemu Paajanen; Janne Penttinen; Hannu Kokki; Merja Kokki; Anne M Koivisto; Päivi Hartikainen; Eino Solje; Tuomo Hänninen; Anne Marja Remes; Sanna-Kaisa Herukka
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2016-07-19

Review 7.  The Role of Genetics in Advancing Precision Medicine for Alzheimer's Disease-A Narrative Review.

Authors:  Yun Freudenberg-Hua; Wentian Li; Peter Davies
Journal:  Front Med (Lausanne)       Date:  2018-04-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.